---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-26-006815"
form_type: "8-K"
ticker: "AEMD"
cik: "0000882291"
company_name: "AETHLON MEDICAL INC"
filed_at: "2026-08-31T13:15:13+00:00"
generated_at: "2026-08-31T13:16:15.016824+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Aethlon Medical: all pre-funded warrants exercised; 1,604,095 shares outstanding

## Summary
- As of Aug 28, 2026, Aethlon Medical has 1,604,095 common shares outstanding.
- All previously outstanding pre-funded warrants have been exercised.
- CEO and CFO James B. Frakes signed the 8-K on Aug 31, 2026.

## SEC filing metadata
- accession: 0001683168-26-006815
- form_type: 8-K
- ticker: AEMD
- cik: 0000882291
- company_name: AETHLON MEDICAL INC
- filed_at: 2026-08-31T13:15:13+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/882291/000168316826006815/0001683168-26-006815-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/882291/000168316826006815/aethlon_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-26-006815
- JSON: https://secwatch.observer/filing/0001683168-26-006815.json
- Plain text: https://secwatch.observer/filing/0001683168-26-006815.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.